Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral 1,2 Diols. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108753851B details a novel ChKRED12 enzyme method for producing high-purity chiral 1,2-diols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.